Search Results 1981-1990 of 24168 for Periods

  1. A Study Comparing The Effectiveness And Safety Of The Morning Injection Of Toujeo Versus Lantus In Patients With Type 1 Diabetes Mellitus - Mayo Clinic

    ... period; Pregnant or breast-feeding women or planning pregnancy during the ... Inappropriate CGM use during screening period evidenced by failure to ...

  2. Hemodialysis - Mayo Clinic

    Diabetes · High blood pressure (hypertension) · Kidney inflammation (glomerulonephritis) · Kidney cysts (polycystic kidney disease) · Inherited kidney diseases ...

  3. Research With I-124 EVuzamitide To Elucidate Cardiac AmyLoidosis - Mayo Clinic

    ... period and for at least 30 days after administration of I-124 evuzamitide. ... For AL and ATTR: Patients may enter the screening period of a clinical trial ...

  4. Study of BLU-667 in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - Mayo Clinic

    Pralsetinib may be started within these washout periods if considered by the ... period and for at least 30 days after the last dose of study drug. Men ...

  5. Comprehensive patient blood management program can reduce use of transfusions, improve patient outcomes - Mayo Clinic News Network

    For surgical patients, the annual rate of transfusions per 1,000 cases decreased from 762 to 480 over the study period. Among the factors that likely drove ...

  6. A Study To Evaluate The Safety And Effect Of CFZ533 On Patients With Graves' Disease - Mayo Clinic

    ... period before enrollment or during the study period; Treatment with immunomodulatory drugs, such as cyclosporine A, methotrexate, and/or cyclophosphamide ...

  7. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    ... period, for 1 week after study drug discontinuation and for an additional 3 months after). No sperm donation is allowed during the study period, for 1 week ...

  8. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

    Note: If the participant has rapid progressive disease from prior therapy, RLY-2608 may be started within these washout periods ... period and for at least 199 ...

  9. Randomized Study Of Topical Alicaforsen Enema In Antibiotic Refractory Pouchitis - Mayo Clinic

    Subjects will undertake a <2 week screening period to provide baseline data and be assessed for eligibility. At the Baseline visit (Day 1) eligible subjects ...

  10. A Study of PF-08052666/​SGN-MesoC2 in Advanced Solid Tumors - Mayo Clinic

    Archival tumor tissue is required, or, if unavailable, a fresh tumor biopsy (if it is safe and feasible) during the screening period. Participants weighing ...